Cargando…

Genes involved in prostate cancer progression determine MRI visibility

MRI is used to image prostate cancer and target tumors for biopsy or therapeutic ablation. The objective was to understand the biology of tumors not visible on MRI that may go undiagnosed and untreated. Methods: Prostate cancers visible or invisible on multiparametric MRI were macrodissected and exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ping, You, Sungyong, Nguyen, Christopher, Wang, Yanping, Kim, Jayoung, Sirohi, Deepika, Ziembiec, Asha, Luthringer, Daniel, Lin, Shih-Chieh, Daskivich, Timothy, Wu, Jonathan, Freeman, Michael R, Saouaf, Rola, Li, Debiao, Kim, Hyung L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858498/ https://www.ncbi.nlm.nih.gov/pubmed/29556354 http://dx.doi.org/10.7150/thno.23180

Ejemplares similares

Retrospective T2 quantification from conventional weighted MRI of the prostate based on deep learning
por: Sun, Haoran, et al.
Publicado: (2023)

Prospective Pilot Trial to Evaluate a High Resolution Diffusion-Weighted MRI in Prostate Cancer Patients
por: Sharif-Afshar, Ali-Reza, et al.
Publicado: (2016)

Free-breathing non-contrast MRA with efficiency-adaptive self navigation
por: Xie, Yibin, et al.
Publicado: (2013)

'Omics' Approaches to Understanding Interstitial Cystitis/Painful Bladder Syndrome/Bladder Pain Syndrome
por: You, Sungyong, et al.
Publicado: (2012)

A Synthetic Form of Frizzled 8-Associated Antiproliferative Factor Enhances p53 Stability through USP2a and MDM2
por: Kim, Jayoung, et al.
Publicado: (2012)

Biomarker discovery and beyond for diagnosis of bladder diseases
por: Jung, Sungyong, et al.
Publicado: (2020)

ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
por: Freeman, Michael R., et al.
Publicado: (2019)

Application of Low-Cost, Easy-to-Use, Portable Biosensor Systems for Diagnosing Bladder Dysfunctions
por: Myung, Nosang V., et al.
Publicado: (2019)

Quantitative proteomic analysis of prostate tissue specimens identifies deregulated protein complexes in primary prostate cancer
por: Zhou, Bo, et al.
Publicado: (2019)

Quick overview of diagnostic kits and smartphone apps for urologists during the COVID-19 pandemic: a narrative review
por: Park, Hyusim, et al.
Publicado: (2021)

RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
por: Chu, Gina Chia-Yi, et al.
Publicado: (2014)

Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects
por: Shahid, Muhammad, et al.
Publicado: (2020)

S-Palmitoylation as a Functional Regulator of Proteins Associated with Cisplatin Resistance in Bladder Cancer
por: Shahid, Muhammad, et al.
Publicado: (2020)

Urinary Metabolite Profiling Combined with Computational Analysis Predicts Interstitial Cystitis-Associated Candidate Biomarkers
por: Wen, He, et al.
Publicado: (2014)

Tumor-Activatable Clinical Nanoprobe for Cancer Imaging
por: Reichel, Derek, et al.
Publicado: (2019)

Intraoperative assessment and postsurgical treatment of prostate cancer tumors using tumor-targeted nanoprobes
por: Teh, James, et al.
Publicado: (2021)

Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer
por: Pellinen, Teijo, et al.
Publicado: (2022)

Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer
por: Li, Lin, et al.
Publicado: (2023)

Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells
por: Li, Qinlong, et al.
Publicado: (2016)

Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism
por: Yeon, Austin, et al.
Publicado: (2018)

Classification of the urinary metabolome using machine learning and potential applications to diagnosing interstitial cystitis
por: Tong, Feng, et al.
Publicado: (2020)

Menthol, a unique urinary volatile compound, is associated with chronic inflammation in interstitial cystitis
por: Shahid, Muhammad, et al.
Publicado: (2018)

Looking to the metabolic landscapes for prostate health monitoring
por: Kim, Wun-Jae, et al.
Publicado: (2017)

Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
por: Giganti, Francesco, et al.
Publicado: (2022)

Integration of proteomic and transcriptomic profiles identifies a novel PDGF-MYC network in human smooth muscle cells
por: Yang, Wei, et al.
Publicado: (2014)

Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis
por: Norris, Joseph M., et al.
Publicado: (2020)

Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental Pathophysiology
por: Kim, Jayoung, et al.
Publicado: (2021)

Automated deep-learning system in the assessment of MRI-visible prostate cancer: comparison of advanced zoomed diffusion-weighted imaging and conventional technique
por: Hu, Lei, et al.
Publicado: (2023)

Partial-gland Cryoablation Outcomes for Localized Prostate Cancer in Patients with Magnetic Resonance Imaging (MRI)-visible and MRI-invisible Lesions
por: Zhu, Alec, et al.
Publicado: (2023)

TP53 structural variants in metastatic prostatic carcinoma
por: Sirohi, Deepika, et al.
Publicado: (2019)

fMRI in anxiety
por: Schunck, Thérèse, et al.
Publicado: (2003)

Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential
por: Miller, Eric T., et al.
Publicado: (2020)

Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1A
por: Shahid, Muhammad, et al.
Publicado: (2018)

Author Correction: Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1A
por: Shahid, Muhammad, et al.
Publicado: (2018)

Virus encoded circulatory miRNAs for early detection of prostate cancer
por: Kim, Jayoung, et al.
Publicado: (2015)

MicroRNA-185 and 342 Inhibit Tumorigenicity and Induce Apoptosis through Blockade of the SREBP Metabolic Pathway in Prostate Cancer Cells
por: Li, Xiangyan, et al.
Publicado: (2013)

SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer
por: Gururajan, Murali, et al.
Publicado: (2015)

Antiproliferative Factor Signaling and Interstitial Cystitis/Painful Bladder Syndrome
por: Kim, Jayoung, et al.
Publicado: (2011)

The significance of the visible tumor on preoperative magnetic resonance imaging in localized prostate cancer
por: Shin, Teak Jun, et al.
Publicado: (2021)

On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances
por: Yan, Yiwu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f5v8jvd6h266fgvugr20plsjnp